Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons
Materials Chemistry Frontiers · 2024 · 8 (19) · 3106-3135
DOI: 10.1039/d4qm00479e ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Chemistry Frontiers, 2024. Verfasst von YunFeng Qu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
The application and optimization of circRNA-LNP.
Förderung
- National Natural Science Foundation of China
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Qu, Y., Liu, R., Sun, D., & Dai, Z. (2024). Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons. Materials Chemistry Frontiers, 8(19), 3106-3135. https://doi.org/10.1039/d4qm00479e
Vancouver
Qu Y, Liu R, Sun D, Dai Z. Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons. Materials Chemistry Frontiers. 2024;8(19):3106-3135. doi:10.1039/d4qm00479e
BibTeX
@article{Qu2024,
author = {Qu, YunFeng and Liu, Renfa and Sun, Desheng and Dai, Zhifei},
title = {Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons},
journal = {Materials Chemistry Frontiers},
year = {2024},
volume = {8},
number = {19},
pages = {3106--3135},
doi = {10.1039/d4qm00479e}
}
EUVIMED